Spencer Pharmaceutical Inc.; Order of Suspension of Trading

---
identifier: "/us/fr/2012-30665"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Spencer Pharmaceutical Inc.; Order of Suspension of Trading"
title_number: 0
title_name: "Federal Register"
section_number: "2012-30665"
section_name: "Spencer Pharmaceutical Inc.; Order of Suspension of Trading"
positive_law: false
currency: "2012-12-19"
last_updated: "2012-12-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Securities and Exchange Commission"
document_number: "2012-30665"
document_type: "notice"
publication_date: "2012-12-19"
agencies:
  - "Securities and Exchange Commission"
fr_citation: "77 FR 75223"
fr_volume: 77
docket_ids:
  - "File No. 500-1"
---


#  Spencer Pharmaceutical Inc.; Order of Suspension of Trading

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Spencer Pharmaceutical Inc. (“Spencer”) because of questions regarding the accuracy of publicly disseminated information, concerning, among other things: (1) The company's current financial condition; and (2) statements made by Spencer in press releases concerning, among other things, an unsolicited buyout offer of Spencer by a foreign company.

The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company.

*Therefore, it is ordered,* pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company, and any equity securities of any entity purporting to succeed to this issuer, is suspended for the period from 9:30 a.m. EST on Monday, December 17, 2012, through 11:59 p.m. EST on Monday, December 31, 2012.

By the Commission.

Elizabeth M. Murphy,

Secretary.